Current perspectives on cardiovascular outcome trials in diabetes

Cardiovascular disease (CVD) is one of the most common diabetes-associated complications, as well as a leading cause for death in type 2 diabetes patients (T2D). Despite the well-known correlation between the two, up until the 2008 FDA industry guidance for licensing of new anti-hyperglycemic drugs,...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnell, Oliver, Rydén, Lars, Standl, Eberhard, Ceriello, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045635/
https://www.ncbi.nlm.nih.gov/pubmed/27716274
http://dx.doi.org/10.1186/s12933-016-0456-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045635/
https://www.ncbi.nlm.nih.gov/pubmed/27716274
http://dx.doi.org/10.1186/s12933-016-0456-8

Ejemplares similares